While it is disappointing that existing shareholders can't participate I can appreciate that this a more cost effective option.I do however take issue with the size of the discount that has been offered. 26% appears far too large and given it was oversubscribed this reinforces this view.I could of lived with 4c but 3.5c (under the 52 week low) is far too cheap and is doing existing shareholders a disservice.
- Forums
- ASX - By Stock
- TBA
- Ann: Suspension from Official Quotation
Ann: Suspension from Official Quotation, page-11
-
- There are more pages in this discussion • 29 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add TBA (ASX) to my watchlist
|
|||||
Last
2.6¢ |
Change
0.000(0.00%) |
Mkt cap ! $33.12M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Featured News
TBA (ASX) Chart |
Day chart unavailable
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham / Dr Alan Dunton, MD & CEO / Non-Executive Director
James Graham / Dr Alan Dunton
MD & CEO / Non-Executive Director
SPONSORED BY The Market Online